SMO and pancreatic neoplasm: The knockdown of SMO could inhibit pancreas cancer cells in terms of self-renewal, epithelial–mesenchymal transition (EMT), invasion, migration, lung metastasis, chemoresistance to gemcitabine and development of pancreatic cancer stem cells [95].